X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2635) 2635
Publication (203) 203
Book Review (62) 62
Magazine Article (17) 17
Book Chapter (14) 14
Newsletter (11) 11
Newspaper Article (11) 11
Conference Proceeding (6) 6
Trade Publication Article (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
glatiramer acetate (2435) 2435
humans (1767) 1767
multiple sclerosis (1646) 1646
index medicus (1143) 1143
clinical neurology (953) 953
female (847) 847
multiple sclerosis - drug therapy (846) 846
peptides - therapeutic use (749) 749
neurosciences (703) 703
male (673) 673
adult (668) 668
double-blind (588) 588
immunosuppressive agents - therapeutic use (536) 536
animals (504) 504
interferon-beta - therapeutic use (492) 492
multiple sclerosis, relapsing-remitting - drug therapy (456) 456
middle aged (455) 455
neurology (393) 393
experimental autoimmune encephalomyelitis (386) 386
placebo-controlled trial (381) 381
immunology (368) 368
treatment outcome (368) 368
multiple sclerosis - immunology (330) 330
interferon-beta (327) 327
pharmacology & pharmacy (324) 324
interferon beta-1a (314) 314
multiple-sclerosis (312) 312
immunologic factors - therapeutic use (294) 294
disability (287) 287
natalizumab (283) 283
disease progression (279) 279
magnetic resonance imaging (276) 276
multicenter (274) 274
adjuvants, immunologic - therapeutic use (258) 258
interferon beta-1b (252) 252
central-nervous-system (250) 250
drug therapy (250) 250
myelin basic-protein (232) 232
mice (231) 231
therapy (231) 231
care and treatment (227) 227
interferon (224) 224
interferon beta (214) 214
research (204) 204
experimental allergic encephalomyelitis (202) 202
peptides - administration & dosage (194) 194
peptides - pharmacology (194) 194
analysis (191) 191
copolymer 1 (190) 190
medicine & public health (186) 186
peptides - adverse effects (186) 186
multiple sclerosis - therapy (185) 185
t-cells (185) 185
multiple sclerosis - pathology (173) 173
disease (159) 159
health aspects (159) 159
immunosuppressive agents - adverse effects (156) 156
young adult (156) 156
immunosuppressive agents - administration & dosage (154) 154
multiple sclerosis - physiopathology (152) 152
psychiatry (152) 152
glatiramer acetate - therapeutic use (149) 149
time factors (148) 148
fingolimod (140) 140
multiple sclerosis - diagnosis (140) 140
recurrence (140) 140
inflammation (138) 138
adolescent (137) 137
medicine, general & internal (134) 134
disability evaluation (133) 133
relapse rate (132) 132
copaxone (128) 128
immunosuppressive agents - pharmacology (127) 127
neuroprotection (125) 125
t cells (121) 121
brain - pathology (120) 120
clinical trials as topic (120) 120
remitting multiple-sclerosis (120) 120
immunotherapy (119) 119
retrospective studies (119) 119
biological response modifiers (115) 115
disease models, animal (113) 113
interferon-beta - administration & dosage (112) 112
progressive multifocal leukoencephalopathy (112) 112
t-lymphocytes - immunology (111) 111
encephalomyelitis, autoimmune, experimental - immunology (110) 110
encephalomyelitis, autoimmune, experimental - drug therapy (108) 108
mice, inbred c57bl (108) 108
clinical trials (107) 107
mri (107) 107
autoimmunity (106) 106
disease-activity (106) 106
immunomodulation (106) 106
regulatory t-cells (106) 106
cytokines (103) 103
diagnostic-criteria (103) 103
dosage and administration (103) 103
dendritic cells (102) 102
expression (102) 102
multiple sclerosis, relapsing-remitting - immunology (102) 102
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2426) 2426
German (70) 70
Spanish (63) 63
Russian (56) 56
French (20) 20
Japanese (15) 15
Hungarian (13) 13
Czech (10) 10
Portuguese (8) 8
Polish (6) 6
Finnish (5) 5
Chinese (4) 4
Italian (4) 4
Serbian (2) 2
Turkish (2) 2
Dutch (1) 1
Hebrew (1) 1
Korean (1) 1
Norwegian (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Neurology, ISSN 1474-4422, 2008, Volume 7, Issue 10, pp. 903 - 914
Journal Article
Journal Article
CNS Drugs, ISSN 1172-7047, 5/2011, Volume 25, Issue 5, pp. 401 - 414
Journal Article
Journal of the Neurological Sciences, ISSN 0022-510X, 04/2018, Volume 387, pp. 152 - 156
Glatiramer acetate (GA) 40 mg × 3/weekly was approved for the treatment of relapsing-remitting multiple sclerosis (RRMS). While the beneficial effect of GA... 
Glatiramer acetate | DTI | Multiple sclerosis | Tract based spatial statistics | MRI | ACCURATE | MECHANISM | ATROPHY | NEUROSCIENCES | BLACK-HOLES | LESIONS | CLINICAL NEUROLOGY | TRIAL | ROBUST | REGISTRATION | BRAIN | Medicine, Experimental | Medical research
Journal Article
European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 05/2019, Volume 133, pp. 8 - 14
Complex drugs may be either biological, if the active ingredients are derived from a biological source, or non-biological, if obtained by chemical synthesis.... 
NBCD | Complex drug | Glatiramer | Glatiramoid | MULTICENTER | MULTIPLE-SCLEROSIS | SAFETY | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | EQUIVALENCE | Glatiramer acetate | Generic drugs | Independent regulatory commissions | Chemical synthesis
Journal Article